Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAFNA PHARMA vs HIKAL. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAFNA PHARMA HIKAL. BAFNA PHARMA/
HIKAL.
 
P/E (TTM) x 16.1 45.5 35.3% View Chart
P/BV x 2.5 2.9 85.6% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 BAFNA PHARMA   HIKAL.
EQUITY SHARE DATA
    BAFNA PHARMA
Mar-23
HIKAL.
Mar-23
BAFNA PHARMA/
HIKAL.
5-Yr Chart
Click to enlarge
High Rs141456 30.9%   
Low Rs79216 36.4%   
Sales per share (Unadj.) Rs48.8164.1 29.7%  
Earnings per share (Unadj.) Rs4.86.4 75.4%  
Cash flow per share (Unadj.) Rs7.015.2 46.4%  
Dividends per share (Unadj.) Rs01.20 0.0%  
Avg Dividend yield %00.4 0.0%  
Book value per share (Unadj.) Rs31.091.9 33.8%  
Shares outstanding (eoy) m23.66123.30 19.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.32.0 109.9%   
Avg P/E ratio x22.952.8 43.3%  
P/CF ratio (eoy) x15.622.1 70.5%  
Price / Book Value ratio x3.53.7 96.7%  
Dividend payout %018.9 0.0%   
Avg Mkt Cap Rs m2,59641,420 6.3%   
No. of employees `000NANA-   
Total wages/salary Rs m1592,224 7.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,15420,230 5.7%  
Other income Rs m3354 60.5%   
Total revenues Rs m1,18620,284 5.8%   
Gross profit Rs m1572,571 6.1%  
Depreciation Rs m531,090 4.9%   
Interest Rs m20481 4.2%   
Profit before tax Rs m1161,054 11.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3270 1.0%   
Profit after tax Rs m113784 14.5%  
Gross profit margin %13.612.7 107.2%  
Effective tax rate %2.425.6 9.4%   
Net profit margin %9.83.9 253.7%  
BALANCE SHEET DATA
Current assets Rs m8739,683 9.0%   
Current liabilities Rs m4656,908 6.7%   
Net working cap to sales %35.413.7 258.1%  
Current ratio x1.91.4 134.0%  
Inventory Days Days226 6.7%  
Debtors Days Days1,30280 1,633.5%  
Net fixed assets Rs m42315,024 2.8%   
Share capital Rs m237247 95.9%   
"Free" reserves Rs m49811,088 4.5%   
Net worth Rs m73511,335 6.5%   
Long term debt Rs m844,899 1.7%   
Total assets Rs m1,29624,707 5.2%  
Interest coverage x6.73.2 210.0%   
Debt to equity ratio x0.10.4 26.6%  
Sales to assets ratio x0.90.8 108.7%   
Return on assets %10.35.1 201.6%  
Return on equity %15.46.9 223.2%  
Return on capital %16.79.5 176.4%  
Exports to sales %067.6 0.0%   
Imports to sales %7.925.6 30.7%   
Exports (fob) Rs mNA13,684 0.0%   
Imports (cif) Rs m915,184 1.7%   
Fx inflow Rs m88513,684 6.5%   
Fx outflow Rs m915,184 1.7%   
Net fx Rs m7948,500 9.3%   
CASH FLOW
From Operations Rs m503,153 1.6%  
From Investments Rs m-75-2,923 2.6%  
From Financial Activity Rs m102-77 -132.5%  
Net Cashflow Rs m76153 50.0%  

Share Holding

Indian Promoters % 88.4 68.9 128.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 9.3 -  
FIIs % 0.0 6.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 11.6 31.2 37.1%  
Shareholders   7,367 74,657 9.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAFNA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAFNA PHARM. vs HIKAL CHEMIC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAFNA PHARM. vs HIKAL CHEMIC Share Price Performance

Period BAFNA PHARM. HIKAL CHEMIC S&P BSE HEALTHCARE
1-Day -1.28% -0.32% 1.18%
1-Month -11.90% -5.59% -0.75%
1-Year -4.38% -1.73% 61.82%
3-Year CAGR -19.10% 22.14% 18.16%
5-Year CAGR 47.52% 9.01% 19.79%

* Compound Annual Growth Rate

Here are more details on the BAFNA PHARM. share price and the HIKAL CHEMIC share price.

Moving on to shareholding structures...

The promoters of BAFNA PHARM. hold a 88.4% stake in the company. In case of HIKAL CHEMIC the stake stands at 68.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAFNA PHARM. and the shareholding pattern of HIKAL CHEMIC.

Finally, a word on dividends...

In the most recent financial year, BAFNA PHARM. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

HIKAL CHEMIC paid Rs 1.2, and its dividend payout ratio stood at 18.9%.

You may visit here to review the dividend history of BAFNA PHARM., and the dividend history of HIKAL CHEMIC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.